Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.

Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, Kaufman HL, Kirchhoff T, Lotze MT, Luke JJ, Minn AJ, Politi K, Shultz LD, Simon R, Thórsson V, Weidhaas JB, Ascierto ML, Ascierto PA, Barnes JM, Barsan V, Bommareddy PK, Bot A, Church SE, Ciliberto G, De Maria A, Draganov D, Ho WS, McGee HM, Monette A, Murphy JF, Nisticò P, Park W, Patel M, Quigley M, Radvanyi L, Raftopoulos H, Rudqvist NP, Snyder A, Sweis RF, Valpione S, Zappasodi R, Butterfield LH, Disis ML, Fox BA, Cesano A, Marincola FM; Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups.

J Immunother Cancer. 2019 Jul 4;7(1):167. doi: 10.1186/s40425-019-0640-y.

2.

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.

Bedognetti D, Ceccarelli M, Galluzzi L, Lu R, Palucka K, Samayoa J, Spranger S, Warren S, Wong KK, Ziv E, Chowell D, Coussens LM, De Carvalho DD, DeNardo DG, Galon J, Kaufman HL, Kirchhoff T, Lotze MT, Luke JJ, Minn AJ, Politi K, Shultz LD, Simon R, Thórsson V, Weidhaas JB, Ascierto ML, Ascierto PA, Barnes JM, Barsan V, Bommareddy PK, Bot A, Church SE, Ciliberto G, De Maria A, Draganov D, Ho WS, McGee HM, Monette A, Murphy JF, Nisticò P, Park W, Patel M, Quigley M, Radvanyi L, Raftopoulos H, Rudqvist NP, Snyder A, Sweis RF, Valpione S, Zappasodi R, Butterfield LH, Disis ML, Fox BA, Cesano A, Marincola FM; Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups.

J Immunother Cancer. 2019 May 22;7(1):131. doi: 10.1186/s40425-019-0602-4. Review. Erratum in: J Immunother Cancer. 2019 Jul 4;7(1):167.

3.

Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.

Bose SJ, Bijvelds MJC, Wang Y, Liu J, Cai Z, Bot AGM, de Jonge HR, Sheppard DN.

Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1;317(1):L71-L86. doi: 10.1152/ajplung.00034.2019. Epub 2019 Apr 10.

4.

Melanoma-associated antigen-A and programmed death-ligand 1 expression are associated with advanced urothelial carcinoma.

Faiena I, Astrow SH, Elashoff DA, Jain R, Bot A, Chamie K, Belldegrun AS, Pantuck AJ, Drakaki A.

Cancer Immunol Immunother. 2019 May;68(5):743-751. doi: 10.1007/s00262-019-02316-w. Epub 2019 Feb 21.

PMID:
30790015
5.

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.

Locke FL, Ghobadi A, Jacobson CA, Miklos DB, Lekakis LJ, Oluwole OO, Lin Y, Braunschweig I, Hill BT, Timmerman JM, Deol A, Reagan PM, Stiff P, Flinn IW, Farooq U, Goy A, McSweeney PA, Munoz J, Siddiqi T, Chavez JC, Herrera AF, Bartlett NL, Wiezorek JS, Navale L, Xue A, Jiang Y, Bot A, Rossi JM, Kim JJ, Go WY, Neelapu SS.

Lancet Oncol. 2019 Jan;20(1):31-42. doi: 10.1016/S1470-2045(18)30864-7. Epub 2018 Dec 2.

6.

In this issue: Antibodies and T Cell subtypes in diseases and therapy.

Kumar H, Bot A.

Int Rev Immunol. 2018;37(4):175-176. doi: 10.1080/08830185.2018.1499488. No abstract available.

PMID:
30239264
7.

miR-124-3p is a chronic regulator of gene expression after brain injury.

Vuokila N, Lukasiuk K, Bot AM, van Vliet EA, Aronica E, Pitkänen A, Puhakka N.

Cell Mol Life Sci. 2018 Dec;75(24):4557-4581. doi: 10.1007/s00018-018-2911-z. Epub 2018 Aug 28.

PMID:
30155647
8.

Analytical solution for bending vibration of a thin-walled cylinder rolling on a time-varying force.

Le Bot A, Duval G, Klein P, Lelong J.

R Soc Open Sci. 2018 Jul 11;5(7):180639. doi: 10.1098/rsos.180639. eCollection 2018 Jul.

9.

[Non-infective endocarditis].

Le Bot A, Jégo P, Donal E, Flécher E, Revest M, Tattevin P.

Rev Med Interne. 2018 Oct;39(10):782-791. doi: 10.1016/j.revmed.2018.03.020. Epub 2018 Jun 11. Review. French.

PMID:
29903680
10.

Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL.

Rossi J, Paczkowski P, Shen YW, Morse K, Flynn B, Kaiser A, Ng C, Gallatin K, Cain T, Fan R, Mackay S, Heath JR, Rosenberg SA, Kochenderfer JN, Zhou J, Bot A.

Blood. 2018 Aug 23;132(8):804-814. doi: 10.1182/blood-2018-01-828343. Epub 2018 Jun 12.

11.

In this issue: Role of immune cells and molecules in rheumatoid arthritis pathogenesis and cancer immunotherapy.

Kumar H, Bot A.

Int Rev Immunol. 2018 May 4;37(3):127-128. doi: 10.1080/08830185.2018.1469353. No abstract available.

PMID:
29733768
12.

In this issue: Effect of gut microbiome on mucosal immunity and enteric diseases.

Kumar H, Bot A.

Int Rev Immunol. 2018 Mar 4;37(2):77-78. doi: 10.1080/08830185.2018.1450947. No abstract available.

PMID:
29558285
13.

Cerebral aspergillosis: An emerging opportunistic infection in patients receiving ibrutinib for chronic lymphocytic leukemia?

Gaye E, Le Bot A, Talarmin JP, Le Calloch R, Belaz S, Dupont M, Tattevin P.

Med Mal Infect. 2018 Jun;48(4):294-297. doi: 10.1016/j.medmal.2018.01.003. Epub 2018 Feb 3. No abstract available.

14.

In this issue: Role of specific and non-specific immunity in disease.

Kumar H, Bot A.

Int Rev Immunol. 2018 Jan 2;37(1):1-2. doi: 10.1080/08830185.2018.1432192. No abstract available.

PMID:
29393730
15.

Ability to Cope with Pain Puts Migraine Surgery Patients in Perspective.

Gfrerer L, Lans J, Faulkner HR, Nota S, Bot AGJ, Austen WG Jr.

Plast Reconstr Surg. 2018 Jan;141(1):169-174. doi: 10.1097/PRS.0000000000003955.

PMID:
29280878
16.

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY.

N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10.

17.

In this issue: Cancer immunity and immunotherapy.

Kumar H, Bot A.

Int Rev Immunol. 2017 Nov 2;36(6):313-314. doi: 10.1080/08830185.2017.1398539. No abstract available.

PMID:
29148862
18.

In this issue: Fine tuners of immunity and their role in infectious and non-infectious diseases.

Kumar H, Bot A.

Int Rev Immunol. 2017 Sep 3;36(5):257-258. doi: 10.1080/08830185.2017.1399712. No abstract available.

PMID:
29135341
19.

Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL.

Roberts ZJ, Better M, Bot A, Roberts MR, Ribas A.

Leuk Lymphoma. 2018 Aug;59(8):1785-1796. doi: 10.1080/10428194.2017.1387905. Epub 2017 Oct 23. Review.

PMID:
29058502
20.

Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy.

Kochenderfer JN, Somerville RPT, Lu T, Yang JC, Sherry RM, Feldman SA, McIntyre L, Bot A, Rossi J, Lam N, Rosenberg SA.

Mol Ther. 2017 Oct 4;25(10):2245-2253. doi: 10.1016/j.ymthe.2017.07.004. Epub 2017 Jul 13.

21.

Role of MicroRNAs in shaping innate immunity and as therapeutic targets for autoimmune diseases.

Kumar H, Bot A.

Int Rev Immunol. 2017 May 4;36(3):123-124. doi: 10.1080/08830185.2017.1340043. Epub 2017 Jul 10. No abstract available.

PMID:
28692310
22.

DOC1-Dependent Recruitment of NURD Reveals Antagonism with SWI/SNF during Epithelial-Mesenchymal Transition in Oral Cancer Cells.

Mohd-Sarip A, Teeuwssen M, Bot AG, De Herdt MJ, Willems SM, Baatenburg de Jong RJ, Looijenga LHJ, Zatreanu D, Bezstarosti K, van Riet J, Oole E, van Ijcken WFJ, van de Werken HJG, Demmers JA, Fodde R, Verrijzer CP.

Cell Rep. 2017 Jul 5;20(1):61-75. doi: 10.1016/j.celrep.2017.06.020.

23.

New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016.

Adusumilli PS, Cha E, Cornfeld M, Davis T, Diab A, Dubensky TW Jr, Evans E, Grogan JL, Irving BA, Leidner RS, Olwill SA, Soon-Shiong P, Triebel F, Tuck D, Bot A, Dansey RD, Drake CG, Freeman GJ, Ibrahim R, Patel S, Chen DS.

J Immunother Cancer. 2017 Jun 20;5:50. doi: 10.1186/s40425-017-0253-2. eCollection 2017. Review.

24.

In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy.

Kumar H, Bot A.

Int Rev Immunol. 2017 Jul 4;36(4):205-206. doi: 10.1080/08830185.2017.1326784. Epub 2017 May 24. No abstract available.

PMID:
28537793
25.

Coupling strength assumption in statistical energy analysis.

Lafont T, Totaro N, Le Bot A.

Proc Math Phys Eng Sci. 2017 Apr;473(2200):20160927. doi: 10.1098/rspa.2016.0927. Epub 2017 Apr 19.

26.

In this issue: Innate immunity and infectious diseases-An update.

Kumar H, Bot A.

Int Rev Immunol. 2017 Mar 4;36(2):55-56. doi: 10.1080/08830185.2017.1307021. Epub 2017 Mar 23. No abstract available.

PMID:
28333564
27.

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

Kochenderfer JN, Somerville RPT, Lu T, Shi V, Bot A, Rossi J, Xue A, Goff SL, Yang JC, Sherry RM, Klebanoff CA, Kammula US, Sherman M, Perez A, Yuan CM, Feldman T, Friedberg JW, Roschewski MJ, Feldman SA, McIntyre L, Toomey MA, Rosenberg SA.

J Clin Oncol. 2017 Jun 1;35(16):1803-1813. doi: 10.1200/JCO.2016.71.3024. Epub 2017 Mar 14.

28.

Chronically dysregulated NOTCH1 interactome in the dentate gyrus after traumatic brain injury.

Puhakka N, Bot AM, Vuokila N, Debski KJ, Lukasiuk K, Pitkänen A.

PLoS One. 2017 Mar 8;12(3):e0172521. doi: 10.1371/journal.pone.0172521. eCollection 2017.

29.

Entropy in sound and vibration: towards a new paradigm.

Le Bot A.

Proc Math Phys Eng Sci. 2017 Jan;473(2197):20160602. doi: 10.1098/rspa.2016.0602.

30.

In this issue: Antibodies in pathogenesis and management of diseases.

Kumar H, Bot A.

Int Rev Immunol. 2017 Jan 2;36(1):1-2. doi: 10.1080/08830185.2017.1290936. No abstract available.

PMID:
28215101
31.

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.

Locke FL, Neelapu SS, Bartlett NL, Siddiqi T, Chavez JC, Hosing CM, Ghobadi A, Budde LE, Bot A, Rossi JM, Jiang Y, Xue AX, Elias M, Aycock J, Wiezorek J, Go WY.

Mol Ther. 2017 Jan 4;25(1):285-295. doi: 10.1016/j.ymthe.2016.10.020. Epub 2017 Jan 4.

32.

In This Issue: Cellular and Molecular Mechanisms Orchestrating the Innate Immunity During Infectious and Non-infectious Disease.

Kumar H, Bot A.

Int Rev Immunol. 2016 Sep 2;35(5):369-371. No abstract available.

PMID:
27925494
33.

In This Issue: Protein Structure, Cellular Metabolism, and Genetics in Immunity.

Kumar H, Bot A.

Int Rev Immunol. 2016 Nov;35(6):455-456. No abstract available.

PMID:
27918672
34.

In This Issue: Translational Opportunities for Antibodies: Therapeutics, Biomarkers, and Novel Targets.

Bot A, Kumar H.

Int Rev Immunol. 2016 Jul 3;35(4):291-293. No abstract available.

PMID:
27797621
35.

MBD3 expression and DNA binding patterns are altered in a rat model of temporal lobe epilepsy.

Bednarczyk J, Dębski KJ, Bot AM, Lukasiuk K.

Sci Rep. 2016 Sep 21;6:33736. doi: 10.1038/srep33736.

36.

In This Issue: At the Interaction between the Immune System and Microbes.

Bot A.

Int Rev Immunol. 2016 May 3;35(3):177-8. doi: 10.1080/08830185.2016.1185868. No abstract available.

PMID:
27636907
37.

Etiology matters - Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy.

Dębski KJ, Pitkanen A, Puhakka N, Bot AM, Khurana I, Harikrishnan KN, Ziemann M, Kaspi A, El-Osta A, Lukasiuk K, Kobow K.

Sci Rep. 2016 May 9;6:25668. doi: 10.1038/srep25668.

38.

In This Issue: On Biology of Dendritic Cells and B Cells.

Bot A.

Int Rev Immunol. 2016;35(2):83-4. doi: 10.3109/08830185.2016.1156390. No abstract available.

PMID:
27007189
39.

In This Issue: Molecular, Genetic and Cellular Aspects Related to Primary and Acquired Immunodeficiencies.

Bot A.

Int Rev Immunol. 2016;35(1):4-6. doi: 10.3109/08830185.2016.1139993. No abstract available.

PMID:
26959801
40.

Constantin A. Bona, M.D., Ph.D.

Bot A, Bailey C, Brumeanu T, Casares S, Kuppuswamy K, Zaghouani H.

Int Rev Immunol. 2016;35(1):1-3. doi: 10.3109/08830185.2016.1139991. No abstract available.

PMID:
26959800
41.

Efficacy of Intraoperative Dexmedetomidine Compared with Placebo for Postoperative Pain Management: A Meta-Analysis of Published Studies.

Bellon M, Le Bot A, Michelet D, Hilly J, Maesani M, Brasher C, Dahmani S.

Pain Ther. 2016 Jun;5(1):63-80. doi: 10.1007/s40122-016-0045-2. Epub 2016 Feb 10.

42.

The Phase Behavior of γ-Oryzanol and β-Sitosterol in Edible Oil.

Sawalha H, Venema P, Bot A, Flöter E, Adel RD, van der Linden E.

J Am Oil Chem Soc. 2015;92(11-12):1651-1659. Epub 2015 Nov 2.

43.

In this issue: advances in molecular pathology of inflammatory disorders.

Bot A.

Int Rev Immunol. 2015;34(6):i-ii. doi: 10.3109/08830185.2015.1104119. No abstract available.

PMID:
26553480
44.

Admission From Nursing Home Residence Increases Acute Mortality After Hip Fractures.

van Dijk PA, Bot AG, Neuhaus V, Menendez ME, Vrahas MS, Ring D.

Geriatr Orthop Surg Rehabil. 2015 Sep;6(3):123-9. doi: 10.1177/2151458515570477.

45.

In This Issue: The Multiple Facets of IL-17.

Bot A, Rossi M.

Int Rev Immunol. 2015;34(4):293-4. doi: 10.3109/08830185.2015.1052289.

PMID:
26154077
46.

Radiographs Versus Radiographic Measurements in Distal Radius Fractures.

Neuhaus V, Bot AG, Guitton TG, Ring DC.

J Hand Microsurg. 2015 Jun;7(1):42-8. doi: 10.1007/s12593-014-0164-0. Epub 2014 Oct 21.

47.

Efficacy of intraoperative dexmedetomidine compared with placebo for surgery in adults: a meta-analysis of published studies.

Le Bot A, Michelet D, Hilly J, Maesani M, Dilly MP, Brasher C, Mantz J, Dahmani S.

Minerva Anestesiol. 2015 Oct;81(10):1105-17. Epub 2015 May 25. Review.

48.

Editorial: in this issue.

Bot A.

Int Rev Immunol. 2015 May;34(3):201. doi: 10.3109/08830185.2015.1041855.

PMID:
25945880
49.

A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system.

Chiriva-Internati M, Bot A.

Int Rev Immunol. 2015 Mar;34(2):101-3. doi: 10.3109/08830185.2015.1015888. No abstract available.

PMID:
25901856
50.

Catastrophic Thinking Is Associated With Finger Stiffness After Distal Radius Fracture Surgery.

Teunis T, Bot AG, Thornton ER, Ring D.

J Orthop Trauma. 2015 Oct;29(10):e414-20. doi: 10.1097/BOT.0000000000000342.

PMID:
25866942

Supplemental Content

Support Center